Acinetobacter baumannii has emerged worldwide as an important nosocomial pathogen, causing outbreaks particularly in intensive care units, in wards with patients who have serious underlying illness, and in warm countries [1] . Imipenem is among the drugs of choice for treatment of nosocomial infections due to multidrug-resistant (MDR) A. baumannii isolates. However, their efficacy is being increasingly compromised by the emergence of carbapenem-hydrolysing b-lactamases of molecular Ambler class B (VIM, IMP) and class D (OXA-23, OXA-58) [1] .
The aim of this study was to analyse the molecular mechanisms of carbapenem resistance in A. baumannii and to evaluate carbapenemresistant A. baumannii (CR-Ab) prevalence among all MDR strains isolated at the central hospital of Noumea (CHT), a 285-bed tertiary-referral centre.
Methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus and all Gramnegative bacteria resistant to at least three agents from distinct classes of antibiotics, including extended-spectrum cephalosporin-resistant Enterobacteriaceae, ceftazidime-resistant Pseudomonas aeruginosa, CR-Ab, ceftazidime-resistant Burkholderia spp., and clavulanate-ticarcillin-resistant Stenotrophomonas maltophilia, were considered to be MDR. The study was conducted during the entire year 2004 in the CHT. During that period, 15 320 patients were admitted. All MDR bacteria included were from clinical samples. Colonization and environmental samples were excluded. Only the first sample was analysed for patients who had more than one MDR bacterial episode involving the same strain during the year of the study. The incidence of MDR bacteria acquisition is expressed as the number of MDR bacteria acquisitions per 1000 patient-days in the hospital.
Standard bacteriological techniques and an automated BacT ⁄ Alert system (bioMérieux, Marcy l'Etoile, France) were used to culture bacteria. Bacterial isolates were initially identified by various routine microbiological methods [2] . Identification of A. baumannii isolates was confirmed by the detection and sequencing of the intrinsic bla oxa-51 -like gene [3] . Susceptibility of the isolates to common antibacterial agents was tested using the disk diffusion method, according to CLSI guidelines [4] and the British Society for Antimicrobial Chemotherapy breakpoint for colistin (http://www.bsac.org.uk). MICs of imipenem, meropenem, ceftriaxone, ceftazidime, ampicillin-sulbactam, colistin, rifampicin and tigecycline were determined with the Etest method using Mueller-Hinton agar (Oxoid) according to the manufacturer's recommendations.
Carbapenem-resistant and carbapenem-susceptible A. baumannii isolates were typed by macrorestriction analysis of ApaI-digested chromosomal DNA separated by pulsed-field gel electrophoresis (PFGE), using a CHEF-DR III apparatus (Biorad) with pulses ranging from 5 to 35 s at a voltage of 6 V ⁄ cm at 14°C for 32 h. The criteria used for PFGE pattern interpretation to define epidemiological relatedness were as described by Tenover et al. [5] . DNA extraction (genomic and plasmid) and analysis, isoelectric focusing and conjugation assays with rifampicin-resistant A. baumannii strain CIP 7020 were performed as described previously [6] . Genes coding for Ambler class B and D carbapenemases were sought by PCR using primers specific for bla IMP [7] , bla VIM [8] , bla OXA-58 [9] , bla OXA-23 -like [9] , bla OXA-40 -like [9] and bla OXA-51 ⁄ 69 -like genes [3] . Similarly, the b-lactamase bla TEM and bla AMPC genes, along with ISAbaI, which may be inserted upstream of several b-lactamase genes, were sought by PCR [10, 11] .
In total, 202 single clinical isolates of MDR bacteria were collected during the study period, representing a rate of 1.9 episodes per 1000 patient-days. The distribution of MDR bacteria isolated is shown in Table 1 . CR-Ab (24.8%) ranked third behind expanded-spectrum cephalosporin-resistant Enterobacteriaceae (36.2%) and methicillin-resistant S. aureus (34%). The incidence rate of CR-Ab was 0.48 per 1000 patientdays in hospital, with higher rates in the intensive care unit (1.7) and in the respiratory ward (1.2).
All CR-Ab isolates were resistant to most agents tested: all b-lactams (including imipenem and meropenem), quinolones and aminoglycosides (except for amikacin and tobramycin, which remained active in 90% and 88%, respectively, of the cases). All CR-Ab isolates were susceptible to colistin. The MIC range in mg ⁄ L was as follows: 64 to >256 for ceftazidime, >256 for ceftriaxone, >32 for imipenem and meropenem, 0.5-1 for colistin and rifampicin, 12-24 for ampicillin-sulbactam, and 4 to >256 for tigecycline. CR-Ab represented 64% of all A. baumannii isolates obtained during the entire year 2004 (50 ⁄ 78 strains, data not shown).
Carbapenem-resistant and carbapenem-susceptible A. baumannii isolates were subjected to PFGE (Fig. 1) . Imipenem-susceptible isolates displayed significant variability, and none appeared to be genetically related to carbapenem-resistant isolates, which clustered into a single PFGE type represented by two subtypes, A 1 and A 2 . CR-Ab isolates were found in different wards, across all ethnic and age groups (data not shown), and were seen throughout 2004 at the CHT; moreover, the number of isolates did not follow a clear epidemic curve. The PFGE profile of CR-Ab strains differed from those of the reference strains expressing extended-spectrum b-lactamases, e.g. VEB-1 and PER-1, and from those of strains expressing carbapenem-hydrolysing oxacillinases, e.g. OXA-40 and OXA-58; however, the profiles were very similar to those of the French Polynesian A. baumannii OXA-23 Tah-1 clone [12] .
The A. baumannii isolates tested positive by PCR for the acquired bla OXA-23 -like and bla TEMlike genes, and for the naturally occurring bla OXA-51 -like and bla AMPC -like genes. Sequencing of the amplified fragments confirmed the presence of bla OXA-23 , bla OXA-51 , bla TEM-1 and bla AMPC genes, identical to those identified in A. baumannii OXA-23 Tah-1 [12] . PCR analysis revealed that bla was not embedded in a class 1 integron, but was surrounded by ISAbaI sequences in a manner similar to that of the prototype bla OXA-23 gene, as described by Corvec et al. [10] . Isoelectric focusing analysis confirmed that, in addition to OXA-23 (pI 6.9), the chromosomal class C b-lactamase (pI >9.0) and TEM-1 penicillinase (pI 5.4) were also expressed (data not shown). Plasmid analysis [12] . Cluster analysis was performed by the unweighted pair group method with arithmetic averages (UPGMA), and the percentage relatedness was calculated using the band-based Dice coefficient with a tolerance setting of 1.5% band tolerance and 1.5% optimization. Only bands above 48 kb were considered for analysis. Isolates corresponding to an 87% clustering threshold were considered to belong to the PFGE pattern [20] . Gel images were analysed with BioNumerics version 4.5 software (Applied Maths, Kortrijk, Belgium).
revealed a 60-kb plasmid, albeit inconsistently. If detected, it was transferred to rifampicin-resistant A. baumannii CIP 7020 (at a low frequency of transfer, 10
). This plasmid carries only the bla OXA-23 gene, OXA-23, without additional antibiotic resistance markers.
Outbreaks of OXA-23-producing A. baumannii isolates have been reported repeatedly in Europe, South America and Asia [12] [13] [14] [15] [16] . This study identified an OXA-23-positive A. baumannii clone with an alarmingly high frequency among all MDR bacteria in 2004. The frequency of isolation of CR-Ab in this study was as high as that of methicillin-resistant S. aureus and expanded-spectrum cephalosporin-resistant Enterobacteriaceae; this is unusual and worrying, as a prevalence of <1% has been described by the national French network (the Nosocomial Infection Alert, Investigation and Surveillance Network, http:// www.invs.sante.fr/surveillance/raisin). CR-Ab isolation varies widely in different countries [13] and has been mostly sporadic. Interestingly, in New Caledonia, a retrospective analysis of our bacteriology database of antibiotic resistance susceptibility patterns revealed that this CR-Ab strain might have been present in the hospital since at least December 2001, and has now spread to all wards of the hospital. The recently described AbOXA-23 strain Tah-1, responsible for an outbreak in French Polynesia [12] , showed 100% identity in PFGE patterns and resistance gene characterization with some New Caledonian isolates. Tahiti, an island also located in the Pacific Ocean, but separated from New Caledonia by about 6000 km, illustrates the extent of the geographical distribution of this carbapenemase gene in the South Pacific region. Moreover, clinical strains isolated in 2005 in Westmead Hospital, Sydney (Australia), with an identical antibiotic susceptibility profile, displayed a similar PFGE pattern and expressed OXA-23 in a manner similar to the endemic CR-Ab strain (S. Le Hello, personal communication).
In conclusion, in New Caledonia, OXA-23-producing A. baumannii isolates represent an endemic lineage, which is present in neighbouring countries in the Pacific. These findings highlight the importance of being aware of local specificities in MDR bacterial ecology and resistance levels for initiating proper antimicrobial empirical therapy and for implementing effective infection control policies in a general hospital.
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